Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
CANC
55
HOLDINGS
24%
ALSO IN BBP
BBP
67
HOLDINGS
21%
ALSO IN CANC
SECTOR DRIFT (CANC minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 2.3% | 1.7% | 1.7% |
|
AMGEN INC | 2.4% | 1.6% | 1.6% |
|
SYNDAX PHARMACEUTICALS INC | 1.7% | 1.6% | 1.6% |
|
BRIDGEBIO PHARMA, INC. | 5.3% | 1.6% | 1.6% |
|
HALOZYME THERAPEUTICS INC | 1.5% | 1.7% | 1.5% |
CANC Overweight Relative to BBP
|
REVOLUTION MEDICINES, INC. | 6.1% |
 |
NOVARTIS AG | 4.9% |
 |
ASTRAZENECA PLC | 4.7% |
|
ELI LILLY & CO | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 4.3% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 4.1% |
|
MERCK & CO. INC. | 3.9% |
|
BRIDGEBIO PHARMA, INC. | 3.7% |
 |
GENMAB A/S SPONSORED ADR | 3.3% |
|
NUVALENT, INC. CLASS A | 3.2% |
CANC Underweight Relative to BBP
|
DYNAVAX TECHNOLOGIES CORP | -2.2% |
|
AMICUS THERAPEUTICS INC | -2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.9% |
|
AXSOME THERAPEUTICS, INC. | -1.9% |
|
MIRUM PHARMACEUTICALS, INC. | -1.9% |
|
PHATHOM PHARMACEUTICALS, INC. | -1.8% |
|
BIOMARIN PHARMACEUTICAL INC | -1.7% |
|
TRAVERE THERAPEUTICS, INC. | -1.7% |
|
INCYTE CORP | -1.6% |
 |
THERAVANCE BIOPHARMA INC | -1.6% |